LGALS3 and diffuse large B-cell lymphoma: Similarly, in DLBCL, multiple studies associated overexpressed Gal-3 with increased cell proliferation, survival, and disease aggressiveness and identified GAL-3 as a prognostic factor and potential target for therapy [127,128,129,130,131,132,133].